Research advances in antiviral drugs and their treatment regimens in chronic hepatitis C / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 2200-2204, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-663305
ABSTRACT
Chronic hepatitis C has become a serious public health issue around the world.In recent years,with the development of pharmacotherapy for hepatitis C,it may be possible to cure hepatitis C.With reference to the epidemic status of hepatitis C and the advantages and side effects of conventional standard therapy (pegylated interferon plus ribavirin) and various oral direct-acting antiviral agents (DAAs),this article summarizes the advantages and disadvantages of different combinations of DAAs in the treatment of chronic hepatitis C with different genotypes and briefly introduces the World Health Organization recommendations on the treatment of hepatitis C.Hepatitis C is expected to be eliminated with the development of pharmacotherapy for chronic hepatitis C.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Practice guideline
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS